In this report, Prosthetic heart valve market has been segmented based on type of valve and region. On basis of type of valve, market is segmented into transcatheter heart valves, tissue heart valves, and mechanical heart valves.
The Prosthetic heart valves market categorized as transcatheter heart valves, tissue heart valves, & mechanical heart valves. Transcatheter heart valves segment expected to register highest CAGR during forecasting period. Factors like rising prevalence of aortic stenos is, increasing pool of patients owing to approvals for extended valve indications, and technological advancements are supporting growth of this segment.
Complete report on Prosthetic Heart Valve Market spread across 156 Pages, Profiling 13 Companies and Supported with 64 Tables and 35 Figures is now available at http://www.reportsnreports.com/reports/483910-prosthetic-heart-valve-market-by-type-mechanical-transcatheter-tissue-and-geography-americas-europe-asia-pacific-middle-east-africa-global-forecast-to-2020.html .
North America expected to dominate Prosthetic heart valves market, followed by Europe, Asia-Pacific, & Rest of the World (RoW). This regional segment also projected to register highest CAGR during forecast period. Factors like rapid growth in aging population & prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to growth of North American Prosthetic heart valves market.
Prosthetic Heart Valve Market Report is useful foe following audience
- Prosthetic Heart Valve Manufacturing Companies
- Suppliers and Distributors of Prosthetic Heart Valves
- Healthcare Service Providers
- Teaching Hospitals and Academic Medical Centers (AMCs)
- Health Insurance Players
- Research and Consulting Firms
- Medical Research Institutes
- Audiology Centers
- Healthcare Institutions/Providers (Hospitals, Medical Institutes, and Governing Bodies)
- Venture Capitalists
- Community Centers
- Regulatory Authorities
Transcatheter heart valves segment expected to command largest share of global market in 2017 & is expected to register highest CAGR of 18.0% during forecast period. Large share & high growth rate of this segment can be attributed to rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, & technological advancements.
The key players in Prosthetic heart valve market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), Liva Nova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), Cryo Life, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil).
Click now for more Details, Quiries, Other Information and Order this study “Prosthetic Heart Valve/ Prosthetic Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) – Global Forecast to 2022” report @ http://www.reportsnreports.com/contacts/requestsample.aspx?name=483910
North America expected to dominate Prosthetic heart valve market, followed by Europe, Asia-Pacific, & RoW. North America also expected to register highest CAGR during forecast period. Large share & high growth in this regional segment can be attributed to factors like rapid growth in aging population & prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to growth of North American prosthetic heart valve market.
A majority of leading players in this market are focusing on marketing and promotional activities, product launches and approvals, acquisitions, agreements, collaborations, and expansions to enhance their market presence and strengthen their distribution networks, cater to the needs of a growing customer base, widen their product portfolios, and boost their production capabilities.